Clinical trials
Hodgkin Disease trials in China with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2014 | 1 |
| 2017 | 4 |
| 2019 | 3 |
| 2020 | 4 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 18 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chinese PLA General Hospital | 5 |
| Peking University | 2 |
| Beijing Children's Hospital | 1 |
| Fudan University | 1 |
| Genor Biopharma Co., Ltd. | 1 |
| Han weidong | 1 |
| Hebei Senlang Biotechnology Inc., Ltd. | 1 |
| Immune Cell, Inc. | 1 |
| Institute of Hematology & Blood Diseases Hospital, China | 1 |
| Sun Yat-sen University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hodgkin Disease | 18 |
| Recurrence | 5 |
| Lymphoma, Large-Cell, Anaplastic | 4 |
| Immunoblastic Lymphadenopathy | 2 |
| Lymphoma | 2 |
| Lymphoma, Extranodal NK-T-Cell | 2 |
| Lymphoma, Large B-Cell, Diffuse | 2 |
| Lymphoma, T-Cell | 2 |
| Lymphoma, T-Cell, Peripheral | 1 |
| Nasopharyngeal Carcinoma | 1 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.